30 TECHNOLOGY: UNLOCKING AND DELIVERING THE POTENTIAL OF THERAPEUTIC NITRIC OXIDE

NEW MULTICENTRE CLINICAL TRIAL APPROVED TO PREVENT TRANSMISSION OF COVID-19

New UK clinical trial approved for patients with COPD, including COVID-19

MULTICENTRE STUDY CURRENTLY ENROLLING HOSPITALISED PATIENTS WITH COVID-19

NEW MULTICENTRE CLINICAL TRIAL APPROVED TO PREVENT TRANSMISSION OF COVID-19

New UK clinical trial approved for patients with COPD, including COVID-19

MULTICENTRE STUDY CURRENTLY ENROLLING HOSPITALISED PATIENTS WITH COVID-19

Scroll Down

30 TECHNOLOGY is developing and defining new models of care by unlocking the potential of Nitric Oxide to treat a host of serious medical conditions.

30 TECHNOLOGY Therapeutic Nitric Oxide